BioBuzz

People on the Move: Aaron Vernon Joins Allotera Therapeutics as Acting Chief Technology Officer

Allotera Therapeutics has welcomed Aaron Vernon as Acting Chief Technology Officer, supporting the company’s technical ...
biobuzz

Johns Hopkins Medicine and OpenEvidence Partner to Redesign Medical Education and Clinical Care for the AI Era

Johns Hopkins Medicine and OpenEvidence, a medical AI platform for physicians, announced on October 13, 2026 a strategic collaboration to reimagine medical education and clinical care in the age of ...
BioBuzz

Maryland, Virginia Life Sciences News: Kaléo Wins $96M BARDA Contract, 8 Firms Make TIME HealthTech List & More

The BioHealth Capital Region earned national recognition with eight local companies named to TIME and Statista’s World’s Top ...
BioBuzz

TEDCO Accepts SBA FAST Grant to Expand SBIR/STTR Proposal Lab for Maryland Startups

TEDCO, the Maryland Technology Development Corporation, announced on October 5, 2026 that it has accepted a Federal and State ...
BioBuzz

Buzzin’ Brood Student Spotlight: Sabina Nieto, UC Berkeley

BioBuzz’s Buzzin’ Brood Student Spotlight series celebrates the future of life sciences talent — and the programs, ...
biobuzz

People on the Move: Jonathan Peri, Ph.D., J.D., Joins Citius Oncology’s Board of Directors

Citius Oncology, Inc., an oncology-focused biopharmaceutical company and majority-owned subsidiary of Citius Pharmaceuticals, Inc. (Nasdaq: CTXR), has appointed Jonathan Peri, Ph.D., J.D., as an ...
biobuzz

Jazz Pharmaceuticals to Acquire Actio Biosciences in a Deal Worth Up to $1.32 Billion, Adding a Rare Epilepsy Drug Candidate

Jazz Pharmaceuticals has agreed to acquire Actio Biosciences, the San Diego, California-based clinical-stage biotech, for $820 million upfront plus up to $500 million in additional contingent payments ...